AAAAAA

   
Results: 1-12 |
Results: 12
PHASE I II TRIAL OF THE TYPE-I SOLUBLE RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR IN HIV-1-INFECTED PATIENTS/
Authors: TAKEBE N PAREDES J PINO MC LOWNSBURY WH AGOSTI J KROWN SE
Citation: N. Takebe et al., PHASE I II TRIAL OF THE TYPE-I SOLUBLE RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR IN HIV-1-INFECTED PATIENTS/, Journal of interferon & cytokine research, 18(5), 1998, pp. 321-326
COMPARISON OF NEUTROPHIL AND MONOCYTE FUNCTION BY MICROBICIDAL CELL-KILL ASSAY IN PATIENTS WITH CANCER RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, OR NO CYTOKINE AFTER CYTOTOXIC CHEMOTHERAPY - A PHASE-II TRIAL
Authors: NEMUNAITIS J COX J MEYER W COURTNEY A HANSON T GREENWEAVER C AGOSTI J
Citation: J. Nemunaitis et al., COMPARISON OF NEUTROPHIL AND MONOCYTE FUNCTION BY MICROBICIDAL CELL-KILL ASSAY IN PATIENTS WITH CANCER RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, OR NO CYTOKINE AFTER CYTOTOXIC CHEMOTHERAPY - A PHASE-II TRIAL, American journal of clinical oncology, 21(3), 1998, pp. 308-312
GM-CSF IS SAFE AND EFFECTIVE AS AN ADJUVANT TO INFLUENZA VACCINE IN OLDER ADULTS
Authors: HEUSER M SCHILLING M POWERS D RIFFER E SHOCKEY G BETTIS B WHITMORE J LOWNSBURY W CROSS A AGOSTI J GRAVENSTEIN S
Citation: M. Heuser et al., GM-CSF IS SAFE AND EFFECTIVE AS AN ADJUVANT TO INFLUENZA VACCINE IN OLDER ADULTS, Journal of the American Geriatrics Society, 46(9), 1998, pp. 253-253
A DOUBLE-BLINDED, RANDOMIZED, PLACED (P) CONTROLLED PILOT-STUDY OF RHG-CSF (GM) IN LOW-BIRTH-WEIGHT NEONATES (LBWN) - PRELIMINARY-RESULTS DEMONSTRATE A SIGNIFICANT REDUCTION IN NOSOCOMIAL INFECTIONS WITH RHUGM-CSF
Authors: PUPPALA B CAIRO MS FANAROFF A RAMANATHAN R GIVNER L LAVER J NESIN M WHEELER G AGOSTI J
Citation: B. Puppala et al., A DOUBLE-BLINDED, RANDOMIZED, PLACED (P) CONTROLLED PILOT-STUDY OF RHG-CSF (GM) IN LOW-BIRTH-WEIGHT NEONATES (LBWN) - PRELIMINARY-RESULTS DEMONSTRATE A SIGNIFICANT REDUCTION IN NOSOCOMIAL INFECTIONS WITH RHUGM-CSF, Journal of investigative medicine, 44(7), 1996, pp. 367-367
A DOUBLE-BLINDED, RANDOMIZED, PLACEBO (P) CONTROLLED PILOT-STUDY OF RHGM-CSF (GM) IN LOW-BIRTH-WEIGHT NEONATES (LBWN) - PRELIMINARY-RESULTSDEMONSTRATE A SIGNIFICANT REDUCTION IN NOSOCOMIAL INFECTIONS WITH RHUGM-CSF
Authors: CAIRO MS SETH T FANAROFF A PUPPALA B DELEMOS R GIVNER L LAVER J NESIN M AGOSTI J
Citation: Ms. Cairo et al., A DOUBLE-BLINDED, RANDOMIZED, PLACEBO (P) CONTROLLED PILOT-STUDY OF RHGM-CSF (GM) IN LOW-BIRTH-WEIGHT NEONATES (LBWN) - PRELIMINARY-RESULTSDEMONSTRATE A SIGNIFICANT REDUCTION IN NOSOCOMIAL INFECTIONS WITH RHUGM-CSF, Pediatric research, 39(4), 1996, pp. 1746-1746
PHASE-III RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RHGM-CSF FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: NEMUNAITIS J ROSENFELD CS ASH R FREEDMAN MH DEEG HJ APPELBAUM F SINGER JW FLOMENBERG N DALTON W ELFENBEIN GJ RIFKIN R RUBIN A AGOSTI J HAYES FA HOLCENBERG J SHADDUCK RK
Citation: J. Nemunaitis et al., PHASE-III RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RHGM-CSF FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(6), 1995, pp. 949-954
IN-VIVO EFFECTS OF COMBINED GM-CSF AND AZT IN PATIENTS WITH HIV DISEASE
Authors: SCADDEN D PICKUS O HAMMER S STRETCHER B BRESNAHAN J GERE J MCGRATH J AGOSTI J
Citation: D. Scadden et al., IN-VIVO EFFECTS OF COMBINED GM-CSF AND AZT IN PATIENTS WITH HIV DISEASE, Blood, 86(10), 1995, pp. 3723-3723
COMPARATIVE EFFICACY OF SOLUBLE RHUIL-1 RECEPTORS TYPE-I AND TYPE-II IN MODULATING THE HEMODYNAMIC, METABOLIC AND INFLAMMATORY CYTOKINE RESPONSE IN A NONHUMAN PRIMATE MODEL OF ENDOTOXIN-SHOCK
Authors: MACVITTIE TJ DOBSON ME FARESE AM VIRCA GD SIMS JE DOWER SK CROSS A HOOVER D KIRSCHNER KF AGOSTI J WILLIAMS DE WIDMER MB
Citation: Tj. Macvittie et al., COMPARATIVE EFFICACY OF SOLUBLE RHUIL-1 RECEPTORS TYPE-I AND TYPE-II IN MODULATING THE HEMODYNAMIC, METABOLIC AND INFLAMMATORY CYTOKINE RESPONSE IN A NONHUMAN PRIMATE MODEL OF ENDOTOXIN-SHOCK, Experimental hematology, 22(8), 1994, pp. 683-683
WILL ADMINISTRATION OF RECOMBINANT GM-CSF TO VERY-LOW-BIRTH-WEIGHT (VLBW) NEONATES (N) DIMINISH NOSOCOMIAL INFECTIONS - RESULTS OF A PHASE-I TRIAL
Authors: CAIRO MS CHRISTENSEN R SENDER L ROSENTHAL J ELLIS R GILLAN E AGOSTI J
Citation: Ms. Cairo et al., WILL ADMINISTRATION OF RECOMBINANT GM-CSF TO VERY-LOW-BIRTH-WEIGHT (VLBW) NEONATES (N) DIMINISH NOSOCOMIAL INFECTIONS - RESULTS OF A PHASE-I TRIAL, Pediatric research, 35(4), 1994, pp. 10000294-10000294
RECOMBINANT TUMOR-NECROSIS-FACTOR RECEPTOR (TNFR-FC) ALTERS ENDOTOXIN-INDUCED ACTIVATION OF THE CONTACT (CS) AND FIBRINOLYTIC (FS) SYSTEMS IN HUMAN VOLUNTEERS
Authors: DELACADENA RA MILLER M STADNICKI A TROPEA M AGOSTI J COLMAN RW SUFFREDINI AF
Citation: Ra. Delacadena et al., RECOMBINANT TUMOR-NECROSIS-FACTOR RECEPTOR (TNFR-FC) ALTERS ENDOTOXIN-INDUCED ACTIVATION OF THE CONTACT (CS) AND FIBRINOLYTIC (FS) SYSTEMS IN HUMAN VOLUNTEERS, Blood, 84(10), 1994, pp. 10000189-10000189
ANOMALOUS ORIGIN OF THE LEFT CORONARY-ARTERY FROM THE PULMONARY-ARTERY IN OLDER ADULTS
Authors: DESALAZAR AO AGOSTI J
Citation: Ao. Desalazar et J. Agosti, ANOMALOUS ORIGIN OF THE LEFT CORONARY-ARTERY FROM THE PULMONARY-ARTERY IN OLDER ADULTS, Journal of thoracic and cardiovascular surgery, 106(3), 1993, pp. 563-563
PHASE-III DOUBLE-BLIND TRIAL OF RHGM-CSF (SARGRAMOSTIN) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT (BMT)
Authors: NEMUNAITIS J ROSENFELD C ASH R FLOMENBERG N FRIEDMAN M DEEG J APPELBAUM F SINGER JW DALTON W ELFENBEIN G RIFKIN R RUBIN A AGOSTI J HAYES FA SHADDUCK RK
Citation: J. Nemunaitis et al., PHASE-III DOUBLE-BLIND TRIAL OF RHGM-CSF (SARGRAMOSTIN) FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANT (BMT), Blood, 82(10), 1993, pp. 10000286-10000286
Risultati: 1-12 |